Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Raising Public Awareness: Educating the public about the dangers of unapproved treatments like BPC-157 can help reduce demand and discourage unethical practices
BPC-157 and GLP-1 medications act through entirely separate biological pathways with no known pharmacological interaction
However, directionally, if the FDA follows the PCAC recommendations, we ballpark the incremental revenue upside for the 503A channel to be roughly in the hundreds of millions of dollars annually -- potentially scaling to a billion-dollar-plus over time to the extent these therapies approach GLP-1-like telehealth penetration
Tendons that seem more fragile
B.ShahN.GomollA
